Cite
HARVARD Citation
Stack, A. et al. (2019). Brentuximab vedotin as monotherapy for unresectable breast implant‐associated anaplastic large cell lymphoma. Clinical case reports. 7 (5), pp. 1003-1006. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stack, A. et al. (2019). Brentuximab vedotin as monotherapy for unresectable breast implant‐associated anaplastic large cell lymphoma. Clinical case reports. 7 (5), pp. 1003-1006. [Online].